|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.784
|
|
|
|
positive regulation of transforming growth factor beta secretion
|
GO:2001203 |
1 |
0.700
|
|
|
|
regulation of transforming growth factor beta secretion
|
GO:2001201 |
1 |
0.641
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.603
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.557
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.545
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.437
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.325
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.303
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.263
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.249
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.232
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.181
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.178
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.178
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.168
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.167
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.154
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.140
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.129
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.126
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.121
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.120
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.118
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.116
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.114
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.112
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.109
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.109
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.107
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.106
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.105
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.105
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.104
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.102
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.101
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.100
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.096
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.095
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.093
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.093
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.092
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.092
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.091
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.087
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.086
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.086
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.086
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.085
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.084
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.083
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.083
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.083
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.081
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.080
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.080
|
|
|
|
negative regulation of myoblast differentiation
|
GO:0045662 |
18 |
0.080
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.080
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.080
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.079
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.079
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.078
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.077
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.075
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.074
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.074
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.073
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.073
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.072
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.072
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.070
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.070
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.070
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.068
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.067
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.067
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.066
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.065
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.064
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.063
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.063
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.062
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.061
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.061
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.060
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.060
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.059
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.058
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.058
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.058
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.058
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.058
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.058
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.056
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.055
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.055
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.054
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.054
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.054
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.054
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.052
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.051
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.051
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.050
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.050
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.050
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.050
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.049
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.049
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.049
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.048
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.048
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.047
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.047
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.047
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.046
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.046
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.044
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.044
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.044
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.043
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.043
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.043
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.043
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.043
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.042
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.042
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.042
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.041
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.041
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.041
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.041
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.041
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.040
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.039
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.039
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.039
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.039
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.038
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.038
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.038
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.038
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.037
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.037
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.037
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.037
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.037
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.037
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.037
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.036
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.036
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.036
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.036
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.036
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.036
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.036
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.035
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.035
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.035
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.035
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.035
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.035
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.034
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.034
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.034
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.034
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.034
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.034
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.033
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.033
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.033
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.033
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.033
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.033
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.033
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.033
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.032
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.032
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.032
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.032
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.032
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.032
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.031
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.031
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.030
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.030
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.030
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.030
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.030
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.030
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.029
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.029
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.029
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.028
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.028
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.028
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.028
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.028
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.027
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.027
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.027
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.027
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.027
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.027
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.027
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.027
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.026
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.026
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.026
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.026
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.026
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.026
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.025
|
|
|
|
negative regulation of epithelial cell migration
|
GO:0010633 |
9 |
0.025
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
12 |
0.025
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.025
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.025
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.025
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.025
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.025
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.025
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.024
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.024
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.024
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.024
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.024
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.024
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.024
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.023
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.023
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.023
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.023
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.023
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.023
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.023
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.023
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.023
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.023
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.023
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.023
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.023
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.023
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.022
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.022
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.022
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.022
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.022
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.022
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.022
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.022
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.022
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.021
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.021
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.021
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.021
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.021
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.021
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.021
|
|
|
|
regulation of blood vessel endothelial cell migration
|
GO:0043535 |
12 |
0.021
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.021
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.021
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.021
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.021
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.021
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.021
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.021
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.021
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.020
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.020
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.020
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.020
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.020
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.020
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.020
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.020
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.020
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.020
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.020
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.020
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.020
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.019
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.019
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.019
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.019
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.019
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.019
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.019
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.019
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.019
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.019
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.019
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.019
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.019
|
|
|
|
retinal cone cell development
|
GO:0046549 |
8 |
0.019
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.019
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.019
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.019
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.019
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.019
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.019
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.018
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.018
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.018
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.018
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.018
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.018
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.018
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.018
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.018
|
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.018
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.018
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.018
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.018
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.018
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.018
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.018
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.018
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.018
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.018
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.018
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.018
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.018
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.018
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.018
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.018
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.017
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.017
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.017
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.017
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.017
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.017
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.017
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.017
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.017
|
|
|
|
regulation of monocyte extravasation
|
GO:2000437 |
2 |
0.017
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.017
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.017
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.017
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.017
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.017
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.017
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.016
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.016
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.016
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.016
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.016
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.016
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.016
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.016
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.016
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.016
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.016
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.016
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.016
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.016
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.016
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.016
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.016
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.016
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.015
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.015
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.015
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.015
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.015
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.015
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.015
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.015
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.015
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.015
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.015
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.015
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.015
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.015
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.015
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.015
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.015
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.015
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.015
|
|
|
|
fat soluble vitamin catabolic process
|
GO:0042363 |
1 |
0.015
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.015
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
19 |
0.015
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.015
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.015
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.015
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.014
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.014
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.014
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.014
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.014
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.014
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.014
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.014
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.014
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.014
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.014
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.014
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.014
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.014
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.014
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.014
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.014
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.014
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.014
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.014
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.014
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.014
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.014
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.014
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.014
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.014
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.013
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.013
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.013
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.013
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.013
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.013
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.013
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.013
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.013
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.013
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.013
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.013
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.013
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.013
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.013
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.013
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.013
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.013
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.013
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.013
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.013
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.013
|
|
|
|
extracellular matrix dependent thymocyte migration
|
GO:0072680 |
1 |
0.013
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.013
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.013
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.013
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.013
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.013
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.013
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.013
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.013
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.013
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.013
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.013
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.013
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.013
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.013
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.013
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.013
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.013
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.012
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.012
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.012
|
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
21 |
0.012
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.012
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.012
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.012
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.012
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.012
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.012
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.012
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.012
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.012
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.012
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.012
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.012
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.012
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.012
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.012
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.012
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.012
|
|
